Congenital adrenal hyperplasia—current insights in pathophysiology, diagnostics, and management
HL Claahsen-van der Grinten, PW Speiser… - Endocrine …, 2022 - academic.oup.com
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting
cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to …
cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to …
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Abstract Treatment for congenital adrenal hyperplasia (CAH) was introduced in the 1950s
following the discovery of the structure and function of adrenocortical hormones. Although …
following the discovery of the structure and function of adrenocortical hormones. Although …
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline
Objective To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase
deficiency clinical practice guideline published by the Endocrine Society in 2010 …
deficiency clinical practice guideline published by the Endocrine Society in 2010 …
Caring for individuals with a difference of sex development (DSD): a consensus statement
The term differences of sex development (DSDs; also known as disorders of sex
development) refers to a heterogeneous group of congenital conditions affecting human sex …
development) refers to a heterogeneous group of congenital conditions affecting human sex …
Congenital adrenal hyperplasia
Congenital adrenal hyperplasia is a group of autosomal recessive disorders encompassing
enzyme deficiencies in the adrenal steroidogenesis pathway that lead to impaired cortisol …
enzyme deficiencies in the adrenal steroidogenesis pathway that lead to impaired cortisol …
Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia
Background Adrenal insufficiency in patients with classic 21-hydroxylase deficiency
congenital adrenal hyperplasia (CAH) is treated with glucocorticoid replacement therapy …
congenital adrenal hyperplasia (CAH) is treated with glucocorticoid replacement therapy …
Management of endocrine disease: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency
A Nordenström, H Falhammar - European journal of …, 2019 - academic.oup.com
Non-classic congenital adrenal hyperplasia (NCAH) is a relatively common disorder
regardless of ethnicity, but most cases are never diagnosed, especially in males. A baseline …
regardless of ethnicity, but most cases are never diagnosed, especially in males. A baseline …
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
DP Merke, RJ Auchus - New England Journal of Medicine, 2020 - Mass Medical Soc
CAH Due to 21-Hydroxylase Deficiency Congenital adrenal hyperplasia, a common
autosomal recessive disorder, is potentially life-threatening in its classic form and may be …
autosomal recessive disorder, is potentially life-threatening in its classic form and may be …
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
GP Finkielstain, MS Kim, N Sinaii… - The Journal of …, 2012 - academic.oup.com
Context: Patients with congenital adrenal hyperplasia (CAH) often suffer from long-term
complications secondary to chronic glucocorticoid therapy and suboptimal treatment …
complications secondary to chronic glucocorticoid therapy and suboptimal treatment …
Endocrine disorders & female infertility
D Unuane, H Tournaye, B Velkeniers… - Best Practice & Research …, 2011 - Elsevier
Female infertility occurs in about 37% of all infertile couples and ovulatory disorders account
for more than half of these. The ovaries are in continuous interaction with the other …
for more than half of these. The ovaries are in continuous interaction with the other …